Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations

Altman, 1991, The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip., Arthritis Rheum, 34, 505, 10.1002/art.1780340502 Altman, 1996, Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society: results from a workshop., Osteoarthritis Cartilage, 4, 217, 10.1016/S1063-4584(05)80101-3 Arends, 2000, Baseline risk as predictor of treatment benefit: three clinical meta-re-analyses., Stat Med, 19, 3497, 10.1002/1097-0258(20001230)19:24<3497::AID-SIM830>3.0.CO;2-H Arnold, 2007, The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia., Pain Med, 8, 633, 10.1111/j.1526-4637.2007.00332.x Arnold, 2004, A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder., Arthritis Rheum, 50, 2974, 10.1002/art.20485 Babul, 2004, Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee., J Pain Symptom Manage, 28, 59, 10.1016/j.jpainsymman.2003.11.006 Backonja, 1998, Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial., JAMA, 280, 1831, 10.1001/jama.280.21.1831 Backonja, 2008, NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study., Lancet Neurol, 7, 1106, 10.1016/S1474-4422(08)70228-X Baron, 2006, Mechanisms of disease: neuropathic paina clinical perspective., Nature Clin Pract Neurology, 2, 95, 10.1038/ncpneuro0113 Baron, 2009, A cross sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory systems., Pain, 146, 34, 10.1016/j.pain.2009.06.001 Bellamy, 1999, Comparative study of self-rating pain scales in rheumatoid arthritis patients., Curr Med Res Opin, 15, 113, 10.1185/03007999909113371 Bellamy, 1999, Comparative study of self-rating pain scales in osteoarthritis patients., Curr Med Res Opin, 15, 121, 10.1185/03007999909113372 Berry, 2006, Bayesian clinical trials., Nat Rev Drug Discov, 5, 27, 10.1038/nrd1927 Beydoun, 2006, Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study., Acta Neurol Scand, 113, 395, 10.1111/j.1600-0404.2006.00631.x Bradley, 2001, Severity of knee pain does not predict a better response to an antiinflammatory dose of ibuprofen than to analgesic therapy in patients with osteoarthritis., J Rheumatol, 28, 1073 Breuer, 2007, A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis., Clin Ther, 29, 2022, 10.1016/j.clinthera.2007.09.023 Byas-Smith, 1995, Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage enriched enrollment design., Pain, 60, 267, 10.1016/0304-3959(94)00121-T Cella, 2007, The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group during its first two years., Med Care, 45, S3, 10.1097/01.mlr.0000258615.42478.55 Crofford, 2008, Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin., Pain, 136, 419, 10.1016/j.pain.2008.02.027 Cruccu, 2004, EFNS guidelines on neuropathic pain assessment., Eur J Neurol, 11, 153, 10.1111/j.1468-1331.2004.00791.x Demitrack, 1998, The problem of measurement error in multisite clinical trials., Psychopharmacol Bull, 34, 19 Detke, 2002, Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial., J Clin Psychiatry, 63, 308, 10.4088/JCP.v63n0407 Detke, 2002, Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression., J Psychiatr Res, 36, 383, 10.1016/S0022-3956(02)00060-2 Dogra, 2005, Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study., Eur J Pain, 9, 543, 10.1016/j.ejpain.2004.11.006 Dworkin, 2008, Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia., J Pain, 9, S37, 10.1016/j.jpain.2007.10.008 Dworkin, 2005, Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain., Neurology, 65, S7, 10.1212/WNL.65.12_suppl_4.S7 Dworkin, 2008, Randomized clinical trials of pregabalin for neuropathic pain: methods, results, and implications., Progr Neurother Neuropsychopharmacol, 3, 167, 10.1017/CBO9780511666971.011 Dworkin, 2005, Core outcome measures for chronic pain clinical trials: IMMPACT recommendations., Pain, 113, 9, 10.1016/j.pain.2004.09.012 Dworkin, 2008, Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations., J Pain, 9, 105, 10.1016/j.jpain.2007.09.005 Dyck, 2007, Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity., Diabetes Care, 30, 2619, 10.2337/dc06-2479 Edwards, 2005, Individual differences in endogenous pain modulation as a risk factor for chronic pain., Neurology, 65, 437, 10.1212/01.wnl.0000171862.17301.84 Ellenberg, 2000, Placebo-controlled trials and active-control trials in the evaluation of new treatments, part 2: practical issues and specific cases., Ann Intern Med, 133, 464, 10.7326/0003-4819-133-6-200009190-00015 Evers, 2008, Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies., Cephalalgia, 29, 436, 10.1111/j.1468-2982.2008.01752.x Faries, 2001, The double-blind variable placebo lead-in period: results from two antidepressant clinical trials., J Clin Psychopharmacol, 21, 561, 10.1097/00004714-200112000-00004 Fillingim, 2005, Individual differences in pain responses., Curr Rheumatol Rep, 7, 342, 10.1007/s11926-005-0018-7 Finnerup, 2005, Algorithm for neuropathic pain treatment: an evidence based proposal., Pain, 118, 289, 10.1016/j.pain.2005.08.013 Finnerup, 2002, Lamotrigine in spinal cord injury pain: a randomized controlled trial., Pain, 96, 375, 10.1016/S0304-3959(01)00484-5 Freynhagen, 2005, Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens., Pain, 115, 254, 10.1016/j.pain.2005.02.032 Gallo, 2006, PhRMA Working Group on Adaptive Designs: introduction to the full white paper., Drug Inf J, 40, 421, 10.1177/216847900604000407 Gilron, 2005, Morphine, gabapentin, or their combination for neuropathic pain., N Engl J Med, 352, 1324, 10.1056/NEJMoa042580 Gilron, 2009, Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial., Lancet, 374, 1252, 10.1016/S0140-6736(09)61081-3 Goldstein, 2004, Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine., J Clin Psychopharmacol, 24, 389, 10.1097/01.jcp.0000132448.65972.d9 Greene, 2000, Claims of equivalence in medical research: are they supported by the evidence?, Ann Intern Med, 132, 715, 10.7326/0003-4819-132-9-200005020-00006 Grosskopf, 2006, A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy., Acta Neurol Scand, 114, 177, 10.1111/j.1600-0404.2005.00559.x Hale, 2007, Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study., J Pain, 8, 175, 10.1016/j.jpain.2006.09.011 Hansson, 2009, Toward a definition of pharmacoresistant neuropathic pain., Eur J Pain, 13, 439, 10.1016/j.ejpain.2009.02.008 Hansson, 2007, Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states., Pain, 129, 256, 10.1016/j.pain.2007.03.030 Henanff, 2006, Quality of reporting of noninferiority and equivalence randomized trials., JAMA, 295, 1147, 10.1001/jama.295.10.1147 Hunt, 2001, Reliability of the lumbar flexion, lumbar extension and passive straight leg raise test in normal populations embedded within a complete physical examination., Spine, 26, 2714, 10.1097/00007632-200112150-00018 Irizarry, 2009, Predictors of placebo response in pooled lamotrigine neuropathic pain clinical trials., Clin J Pain, 25, 469, 10.1097/AJP.0b013e31819ddded Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 Jensen, 1993, Increasing the reliability and validity of pain intensity measurement in chronic pain patients., Pain, 55, 195, 10.1016/0304-3959(93)90148-I Jensen, 2003, Translation of symptoms and signs into mechanisms in neuropathic pain., Pain, 102, 1, 10.1016/s0304-3959(03)00006-x Kalso, 2007, Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine., BMC Med, 5, 39, 10.1186/1741-7015-5-39 Katz, 2008, Clinical trial outcome in neuropathic pain: relationship to study characteristics., Neurology, 70, 263, 10.1212/01.wnl.0000275528.01263.6c Katz, 2005, Methodological issues in clinical trials of opioids for chronic pain., Neurology, 65, S32, 10.1212/WNL.65.12_suppl_4.S32 Katz, 2009, Enriched enrollment randomized withdrawal trial designs of analgesics: focus on methodology., Clin J Pain, 9, 797, 10.1097/AJP.0b013e3181b12dec Katz, 2003, Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials., Spine, 28, 851, 10.1097/01.BRS.0000059762.89308.97 Katz, 2007, A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain., Curr Med Res Opin, 23, 117, 10.1185/030079906X162692 Kaul, 2006, Good enough: a primer on the analysis and interpretation of noninferiority trials., Ann Intern Med, 145, 62, 10.7326/0003-4819-145-1-200607040-00011 Khan, 2003, Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports., Neuropsychopharmacology, 28, 552, 10.1038/sj.npp.1300059 Khan, 2004, Research design features and patient characteristics associated with the outcome of antidepressant clinical trials., Am J Psychiatry, 161, 2045, 10.1176/appi.ajp.161.11.2045 Khan, 2008, The persistence of the placebo response in antidepressant clinical trials., J Psychiatr Res, 42, 791, 10.1016/j.jpsychires.2007.10.004 Kirsch, 2008, Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration., PLOS Med, 5, e45, 10.1371/journal.pmed.0050045 Kroenke, 2009, Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial., JAMA, 301, 2099, 10.1001/jama.2009.723 Kobak, 2007, Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?, J Clin Psychopharm, 27, 1, 10.1097/JCP.0b013e31802eb4b7 Lambert, 2000, Incorporating patient preferences into randomized trials., J Clin Epidemiol, 53, 163, 10.1016/S0895-4356(99)00146-8 Landau, 2007, Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study., Clin Ther, 29, 2179, 10.1016/j.clinthera.2007.10.010 Landin, 2000, The impact of restrictive entry criterion during the placebo lead-in period., Biometrics, 56, 271, 10.1111/j.0006-341X.2000.00271.x Lang, 1990, The use of a run-in to enhance compliance., Stat Med, 9, 87, 10.1002/sim.4780090115 Lauritsen, 2004, Symptom recording in a randomizes clinical trial: paper diaries vs. electronic or telephone data capture., Control Clin Trials, 25, 585, 10.1016/j.cct.2004.09.001 Leber, 1989, Hazards of inference: the active control investigation., Epilepsia, 30, S57, 10.1111/j.1528-1157.1989.tb05816.x Leber, 1991, The future of controlled clinical trials: is there an alternative to the randomized controlled trial?, Psychopharmacol Bull, 27, 3 Leber, 1998, Threats to the validity of clinical trials employing enrichment strategies for sample selection., Control Clin Trials, 19, 178, 10.1016/S0197-2456(97)00118-9 Lee, 2004, Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation., Depress Anxiety, 19, 10, 10.1002/da.10134 Lemmens, 2006, Enriched analgesic efficacy studies: an assessment by clinical trial simulation., Contemp Clin Trials, 27, 165, 10.1016/j.cct.2005.10.005 Maheu, 2006, Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International., Osteoarthritis Cartilage, 14, 303, 10.1016/j.joca.2006.02.010 Mallinckrodt, 2007, Simple options for improving signal detection in antidepressant clinical trials., Psychopharm Bull, 40, 101 Max, 1990, Towards physiologically based treatment of patients with neuropathic pain., Pain, 42, 131, 10.1016/0304-3959(90)91156-D McGrath, 2008, Core outcome domains and measures for pediatric acute and chronicrecurrent pain clinical trials: PedIMMPACT recommendations., J Pain, 9, 771, 10.1016/j.jpain.2008.04.007 McQuay, 2008, Enriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic pain., Pain, 135, 217, 10.1016/j.pain.2008.01.014 Myers, 1987, The consent form as a possible cause of side effects., Clin Pharmacol Ther, 42, 250, 10.1038/clpt.1987.142 Otto, 2007, Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy., Eur J Pain, 11, 572, 10.1016/j.ejpain.2006.08.003 Pablos-Mendez, 1998, Run-in periods in randomized trials: implications for the application of results in clinical practice., JAMA, 279, 222, 10.1001/jama.279.3.222 Perrot, 2009, Should we switch from analgesics to the concept of Pain Modifying Analgesic Drugs (PMADs) in osteoarthritis and rheumatic chronic pain conditions?, Pain, 146, 229, 10.1016/j.pain.2009.07.037 Piaggio, 2006, Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement., JAMA, 295, 1152, 10.1001/jama.295.10.1152 Quessy, 2010, Two-stage enriched enrolment pain trials: a brief review of designs and opportunities for broader application., Pain, 148, 8, 10.1016/j.pain.2009.10.029 Quessy, 2008, Placebo response in neuropathic pain trials., Pain, 138, 479, 10.1016/j.pain.2008.06.024 Raskin, 2004, CAPSS-141 Study Group. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects., Neurology, 63, 865, 10.1212/01.WNL.0000137341.89781.14 Reimherr, 1989, The introductory placebo washout: a retrospective evaluation., Psychiatry Res, 30, 191, 10.1016/0165-1781(89)90160-1 Revicki, 2009, Development and psychometric analysis of the PROMIS pain behavior item bank., Pain, 146, 158, 10.1016/j.pain.2009.07.029 Rog, 2005, Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis., Neurology, 65, 812, 10.1212/01.wnl.0000176753.45410.8b Rolke, 2006, Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values., Pain, 123, 231, 10.1016/j.pain.2006.01.041 Rolke, 2006, Quantitative sensory testing: a comprehensive protocol for clinical trials., Eur J Pain, 10, 77, 10.1016/j.ejpain.2005.02.003 Rosenstock, 2004, Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial., Pain, 110, 628, 10.1016/j.pain.2004.05.001 Rothwell, 2006, Factors that can affect the external validity of randomised controlled trials., PLoS Clin Trials, 1, e9, 10.1371/journal.pctr.0010009 Rowbotham, 2008, The impact of selective publication on clinical research in pain., Pain, 140, 401, 10.1016/j.pain.2008.10.026 Rowbotham, 1998, Gabapentin for the treatment postherpetic neuralgia: a randomized controlled trial., JAMA, 280, 1837, 10.1001/jama.280.21.1837 Rowbotham, 2003, Oral opioid therapy for chronic peripheral and central neuropathic pain., N Engl J Med, 348, 1223, 10.1056/NEJMoa021420 Russell, 2008, Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial., Pain, 136, 432, 10.1016/j.pain.2008.02.024 Sackett, 1980, The competing objectives of randomized trials., N Engl J Med, 303, 1059, 10.1056/NEJM198010303031812 Sackett, 2002, The architecture of diagnostic research., BMJ, 324, 539, 10.1136/bmj.324.7336.539 Schatzberg, 2000, Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression., Biol Psychiatry, 47, 736, 10.1016/S0006-3223(00)00846-5 Schnitzer, 2000, Efficacy of tramadol in treatment of chronic low back pain., J Rheumatol, 27, 772 Schnitzer, 2005, Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee: a combined analysis of the VACT studies., J Rheumatol, 32, 1093 Schwartz, 1967, Explanatory and pragmatic attitudes in therapeutical trials., J Chronic Dis, 20, 637, 10.1016/0021-9681(67)90041-0 Senn, 1994, Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials., Stat Med, 13, 293, 10.1002/sim.4780130310 Silberstein, 2008, Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults., Cephalalgia, 28, 484, 10.1111/j.1468-2982.2008.01555.x Silver, 2007, Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain., J Pain Symptom Manage, 34, 446, 10.1016/j.jpainsymman.2006.12.015 Sindrup, 1999, Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial., Pain, 83, 85, 10.1016/S0304-3959(99)00079-2 Stacey, 2008, Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and tie to onset of pain relief., J Pain, 9, 1006, 10.1016/j.jpain.2008.05.014 Stacey, 2008, Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial., Pain Med, 9, 1202, 10.1111/j.1526-4637.2008.00423.x Straube, 2008, Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain: a systematic review., Br J Clin Pharmacol, 66, 266, 10.1111/j.1365-2125.2008.03200.x Temple, 2000, Placebo-controlled trials and active-control trials in the evaluation of new treatments, part 1: ethical and scientific issues., Ann Intern Med, 133, 455, 10.7326/0003-4819-133-6-200009190-00014 Tesfaye, 2007, Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials., Diabetes Care, 30, 2626, 10.2337/dc07-0608 Thienel, 2004, Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials., Acta Neurol Scand, 110, 221, 10.1111/j.1600-0404.2004.00338.x Treede, 2008, Neuropathic pain: redefinition and a grading system for clinical and research purposes., Neurology, 70, 1630, 10.1212/01.wnl.0000282763.29778.59 Trivedi, 1994, Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?, Neuropsychopharmacology, 11, 33, 10.1038/npp.1994.63 Turk, 2003, Core outcome domains for chronic pain clinical trials: IMMPACT recommendations., Pain, 106, 337, 10.1016/j.pain.2003.08.001 Turk, 2006, Developing outcome measures for pain clinical trials: IMMPACT recommendations., Pain, 125, 208, 10.1016/j.pain.2006.09.028 Turk, 2008, Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations., Pain, 139, 485, 10.1016/j.pain.2008.06.025 Turner, 2002, Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial., Pain, 99, 91, 10.1016/S0304-3959(02)00060-X Vickers, 2004, Statistical reanalysis of four recent randomized trials of acupuncture for pain using analysis of covariance., Clin J Pain, 20, 319, 10.1097/00002508-200409000-00006 Vinik, 2007, Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized double-blind, placebo-controlled studies., Pain, 128, 169, 10.1016/j.pain.2006.09.040 Wasan, 2005, The association between negative affect and opioid analgesia in patients with discogenic low back pain., Pain, 117, 450, 10.1016/j.pain.2005.08.006 Whitney, 1992, Regression to the mean in treated versus untreated chronic pain., Pain, 50, 281, 10.1016/0304-3959(92)90032-7 Woolf, 2004, Pain: moving from symptom control toward mechanism-specific pharmacologic management., Ann Intern Med, 140, 441, 10.7326/0003-4819-140-8-200404200-00010 Woolf, 1998, Towards a mechanism-based classification of pain?, Pain, 77, 227, 10.1016/S0304-3959(98)00099-2 Zakrzewska, 1997, Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial., Pain, 73, 223, 10.1016/S0304-3959(97)00104-8 Zhang, 2008, The placebo effect and its determinants in osteoarthritis., Ann Rhemu Dis, 67, 1716, 10.1136/ard.2008.092015 Ziegler, 2006, Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial., Diabetes Care, 29, 2365, 10.2337/dc06-1216 Ziegler, 2007, Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain., Diabetes Care, 30, 664, 10.2337/dc06-2009 Zimbroff, 2001, Patient and rater education of expectations in clinical trials (PREECT)., J Clin Psychopharmacol, 21, 251, 10.1097/00004714-200104000-00028